PKD Foundation Announces New President and CEO
KANSAS CITY, Mo., Nov. 3, 2011 /PRNewswire-USNewswire/ — The PKD Foundation is pleased to announce Gary Godsey as its new President and Chief Executive Officer, effective Nov. 28, 2011.
The PKD Foundation is a Kansas City-based nonprofit organization which funds Polycystic Kidney Disease (PKD) research and provides a variety of programs to serve the PKD community. PKD is a life-threatening genetic disease affecting 12.5 million men, women and children worldwide.
Godsey brings extensive knowledge of non-profit management to his new role at the PKD Foundation. He served as President and Chief Executive Officer of United Way of Metropolitan Dallas from 2000 to 2011, after a successful career as President of United Way/Capital Area in Austin, Texas. Godsey began his 32-year career in the nonprofit sector when he was hired as Executive Director of the American Cancer Society upon graduation from college.
In making the announcement, Scott Goodman, PKD Foundation Board of Trustees Chairman said, “Gary brings an incredible skill set to the PKD Foundation. His leadership abilities, years of experience, energy and insight will enable him to guide the organization forward, as we work to fulfill our mission to ensure no one suffers the full effects of Polycystic Kidney Disease. We are honored to have Gary as part of our team.”
Godsey was an integral part of the United Way system on the state and national level serving as chair, co-chair or member of numerous committees during his tenure including the United Way of America Staff Leaders Conference, United Way of America Membership Committee, United Way of America’s National Professional Council and the United Ways of Texas board. During his career, Godsey has been responsible for raising over $700 million.
Godsey earned a bachelor’s degree in Health from Tennessee Tech University.
“I am very honored to have been selected for this position,” Godsey said in response to being named to the role. “The PKD Foundation is focused on finding a cure for a disease impacting millions of people worldwide. I look forward to working hand-in-hand with the volunteers, board members and staff, who are so committed to addressing the current needs of patients and their families, while being laser-focused on finding a treatment and cure for PKD. This is a unique and exciting opportunity, one which I am grateful to be part of.”
About the PKD Foundation: Polycystic Kidney Disease (PKD) affects one in 500 people worldwide, regardless of gender, age or ethnicity. More than 600,000 Americans and 12.5 million people around the world suffer from this debilitating genetic disease. The PKD Foundation is dedicated to research to find a treatment and a cure for PKD in addition to education, advocacy and awareness to support the patients and family living with the disease. More information is available at www.pkdcure.org.
SOURCE PKD Foundation